Volitionrx (VNRX) EBIT Growth (1y) (2013 - 2025)
Volitionrx (VNRX) EBIT Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 20.97% |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 90.95% |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -18.12% |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 74.18% |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 16.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.66% |
| Sep 30, 2025 | 13.08% |
| Jun 30, 2025 | 9.91% |
| Mar 31, 2025 | 34.14% |
| Dec 31, 2024 | 33.86% |
| Sep 30, 2024 | 32.18% |
| Jun 30, 2024 | 26.79% |
| Mar 31, 2024 | 7.30% |
| Dec 31, 2023 | -9.11% |
| Sep 30, 2023 | -8.26% |
| Jun 30, 2023 | -17.90% |
| Mar 31, 2023 | -17.82% |
| Dec 31, 2022 | 8.81% |
| Sep 30, 2022 | -5.69% |
| Jun 30, 2022 | -37.26% |
| Mar 31, 2022 | -26.16% |
| Dec 31, 2021 | -55.24% |
| Sep 30, 2021 | -67.89% |
| Jun 30, 2021 | -13.20% |
| Mar 31, 2021 | -3.63% |